Publications by authors named "Aniko Fodor"
Chemotherapy induced thrombopenia (CIT) is difficult to treat, as previous treatment options, including recombinant human thrombopoietin proved to be of limited efficacy. Here we report a case of a mantle cell lymphoma patient treated with intensive chemotherapy, who belongs to Yehova's witnesses and therefore did not accept platelet transfusions. At the time of severe thrombocytopenia (zero thrombocytes/ per mikroliter) and gastrointestinal bleeding, on day 13 following the start of hyperCVAD B chemotherapy, romiplostim treatment was given resulting in quick normalisation of the platelet count followed by thrombocytosis.
View Article and Find Full Text PDFArticle Synopsis
- Splenic marginal zone lymphoma (SMZL) is a rare type of lymphoma, making up only 1% of all cases, and a study reviewed the experiences of 13 patients with this disease.
- Among these patients, prognostic evaluations indicated that 31% had good prognosis, 38% had intermediate, and another 31% had poor prognosis, especially those with high-risk factors like anemia and elevated LDH.
- The presence of autoimmune hemolytic anemia (AIHA) significantly worsens survival rates, leading to a grim outcome with a 100% mortality rate in those affected, indicating that AIHA is an important negative prognostic factor in SMZL.